- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Two Candidates Nominated to Lead California Stem Cell Agency
24 May 2011 3:32 pm
Southern California investor Jonathan Thomas and cardiologist turned entrepreneur Frank Litvack have been nominated to lead the California Institute of Regenerative Medicine (CIRM). Whomever is elected by the board of the stem cell institute when it meets on 23 June will replace real estate developer Robert Klein, who spearheaded the 2004 ballot initiative that created CIRM and has served as its first and only chair.
During Klein's tenure, the agency has had its share of controversy, but has also won praise for building infrastructure for the burgeoning field. A December 2010 report by external scientists concluded that a major priority for the agency going forward should be translating these gains in basic science into therapies. Klein was scheduled to finish his term in December, but after a rocky nomination process failed to produce a viable candidate, the CIRM board reelected Klein to serve a 6-month term until a replacement could be found.
Three of the four state officials charged with nominating a chairperson nominated Thomas, a founding partner at Saybrook Capital in Santa Monica. In his nomination letter, state treasurer Bill Lockyer, wrote that: "Mr. Thomas' experience as a public finance investment banker, attorney, board member of various governmental agencies, and board member of the Crippled Children's Society of Southern California, as well as his lifelong background, education and interest in biology and medical sciences, makes him exceptionally well-suited to fill the role."
State Controller John Chiang bucked the trend, nominating Litvack, whom he praised for a "unique combination of skills" and experience as a clinician, researcher, and entrepreneur. Litvack is currently a partner or chair of several medical technology companies. "Dr. Litvack knows from personal experience what it takes to develop new medical technologies and move them through the regulatory process to adoption in the marketplace," Chiang wrote in his nomination letter.